Ward T. Smith

1.1k total citations
17 papers, 892 citations indexed

About

Ward T. Smith is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, Ward T. Smith has authored 17 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 11 papers in Experimental and Cognitive Psychology and 9 papers in Psychiatry and Mental health. Recurrent topics in Ward T. Smith's work include Treatment of Major Depression (12 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (11 papers) and Electroconvulsive Therapy Studies (5 papers). Ward T. Smith is often cited by papers focused on Treatment of Major Depression (12 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (11 papers) and Electroconvulsive Therapy Studies (5 papers). Ward T. Smith collaborates with scholars based in United States and Japan. Ward T. Smith's co-authors include Peter D. Londborg, Vincent Glaudin, John R. Painter, Robert J. Bielski, Douglas E. Feltner, John Panagides, Dan Zimbroff, Atul C. Pande, Jonathan Davidson and Richard H. Weisler and has published in prestigious journals such as American Journal of Psychiatry, The British Journal of Psychiatry and Journal of Affective Disorders.

In The Last Decade

Ward T. Smith

17 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ward T. Smith United States 13 419 412 298 203 169 17 892
Charles S. Wilcox United States 16 320 0.8× 272 0.7× 275 0.9× 171 0.8× 127 0.8× 27 806
William F. Boyer United States 16 432 1.0× 300 0.7× 360 1.2× 192 0.9× 227 1.3× 27 1.0k
Jay B. Cohn United States 17 554 1.3× 417 1.0× 481 1.6× 220 1.1× 151 0.9× 30 1.2k
Ram Shrivastava United States 16 554 1.3× 443 1.1× 577 1.9× 172 0.8× 246 1.5× 28 1.3k
Peter D. Londborg United States 14 496 1.2× 599 1.5× 344 1.2× 423 2.1× 144 0.9× 19 1.2k
Ole Lemming Denmark 16 486 1.2× 342 0.8× 464 1.6× 301 1.5× 124 0.7× 27 1.1k
Nicholas DeMartinis United States 18 294 0.7× 542 1.3× 272 0.9× 210 1.0× 157 0.9× 35 1.1k
Mary E. Sayler United States 13 561 1.3× 300 0.7× 385 1.3× 239 1.2× 96 0.6× 26 834
A.R. Entsuah Canada 7 703 1.7× 347 0.8× 388 1.3× 99 0.5× 189 1.1× 12 983
Rajinder Judge United States 15 421 1.0× 354 0.9× 333 1.1× 358 1.8× 79 0.5× 17 1.1k

Countries citing papers authored by Ward T. Smith

Since Specialization
Citations

This map shows the geographic impact of Ward T. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ward T. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ward T. Smith more than expected).

Fields of papers citing papers by Ward T. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ward T. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ward T. Smith. The network helps show where Ward T. Smith may publish in the future.

Co-authorship network of co-authors of Ward T. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Ward T. Smith. A scholar is included among the top collaborators of Ward T. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ward T. Smith. Ward T. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Papakostas, George I., Alisabet Clain, Victoria Ameral, et al.. (2009). Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study. International Clinical Psychopharmacology. 25(1). 17–21. 16 indexed citations
2.
Bielski, Robert J., Lynn Cunningham, Joseph P. Horrigan, et al.. (2008). Gepirone Extended-Release in the Treatment of Adult Outpatients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 69(4). 571–577. 31 indexed citations
3.
Shelton, Richard C., Kirsten Haman, Mark Hyman Rapaport, et al.. (2006). A Randomized, Double-Blind, Active-Control Study of Sertraline Versus Venlafaxine XR in Major Depressive Disorder. The Journal of Clinical Psychiatry. 67(11). 1674–1681. 39 indexed citations
4.
Pande, Atul C., Jerri G. Crockatt, Douglas E. Feltner, et al.. (2003). Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial. American Journal of Psychiatry. 160(3). 533–540. 244 indexed citations
5.
Liebowitz, Michael R., Nicholas DeMartinis, Karen L. Weihs, et al.. (2003). Efficacy of Sertraline in Severe Generalized Social Anxiety Disorder. The Journal of Clinical Psychiatry. 64(7). 785–792. 74 indexed citations
6.
Feiger, Alan D., Jon F. Heiser, Ram Shrivastava, et al.. (2003). Gepirone Extended-Release. The Journal of Clinical Psychiatry. 64(3). 243–249. 44 indexed citations
7.
Smith, Ward T., Peter D. Londborg, Vincent Glaudin, & John R. Painter. (2002). Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?. Journal of Affective Disorders. 70(3). 251–259. 51 indexed citations
8.
Smith, Ward T., Douglas E. Feltner, & Richard J. Kavoussi. (2002). Pregabalin in generalized anxiety disorder: Long term efficacy and relapse prevention. European Neuropsychopharmacology. 12. 350–350. 6 indexed citations
9.
Londborg, Peter D., Ward T. Smith, Vincent Glaudin, & John R. Painter. (2000). Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression. Journal of Affective Disorders. 61(1-2). 73–79. 67 indexed citations
10.
Smith, Ward T., et al.. (1999). Pilot Study of Zatosetron (LY277359) Maleate, a 5-Hydroxytryptamine-3 Antagonist, in the Treatment of Anxiety. Journal of Clinical Psychopharmacology. 19(2). 125–131. 10 indexed citations
11.
Londborg, Peter D., Robert Wolkow, Ward T. Smith, et al.. (1998). Sertraline in the treatment of panic disorder. The British Journal of Psychiatry. 173(1). 54–60. 105 indexed citations
12.
Glaudin, Vincent, et al.. (1994). Discriminating placebo and drug in generalized anxiety disorder (GAD) trials: single vs. multiple clinical raters.. PubMed. 30(2). 175–8. 5 indexed citations
13.
Dunbar, G. C., James L. Claghorn, Ari Kiev, Karl Rickels, & Ward T. Smith. (1993). A comparison of paroxetine and placebo in depressed outpatients. Acta Psychiatrica Scandinavica. 87(5). 302–305. 40 indexed citations
14.
Cutler, Neal R., T Fakouhi, Ward T. Smith, et al.. (1993). Evaluation of Multiple Doses of Milacemide in the Treatment of Senile Dementia of the Alzheimer's Type. Journal of Geriatric Psychiatry and Neurology. 6(2). 115–119. 9 indexed citations
15.
Claghorn, James L., Ari Kiev, Karl Rickels, Ward T. Smith, & G. C. Dunbar. (1992). Paroxetine versus placebo: a double-blind comparison in depressed patients.. PubMed. 53(12). 434–8. 42 indexed citations
16.
Smith, Ward T., et al.. (1990). Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder.. PubMed. 26(2). 191–6. 96 indexed citations
17.
Smith, Ward T. & Vincent Glaudin. (1986). Double‐blind efficacy and safety study comparing adinazolam mesylate and placebo in depressed inpatients. Acta Psychiatrica Scandinavica. 74(3). 238–245. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026